• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN LLC VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN LLC VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Reaction (2414)
Event Date 02/01/2017
Event Type  Injury  
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Patient is reported as after partial venectomia of proximal part of both gsvs and crossectomy.The physician used a venaseal closure catheter during procedure.Endovascular adhesive closure of both great saphenous veins performed using venaseal in one session.Approximately 2 days, and approximately 19 days post procedure, no complaints were reported.Dus control was performed with no problems.Approximately 2.5 months post procedure, due to the patient¿s complaints on discomfort from the right, dus was performed.¿thickening of echo-signals along the occluded gsv from the right up to 0.28cm¿ was reported.No fever, edema, and gsv compartment intact was reported.Approximately 7 days later, spontaneous skin perforation from the right occurred.Dus control showed rupture of gsv compartment due to several granulomas along the right gsv.The patient was referred to nush for crossectomy due to proximal growth of granulomas towards deep vein system.7-8 cm of proximal part of gsv was removed and several clinical tests performed: the microbiological test was negative (no infection), histological test showed ¿necrobiosis lipoidica¿.Approximately 1 month later, the same symptoms appeared from the left.The crossectomy and partial venectomia performed.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
The patient's legs were scanned with ultrasound, the patient has healed incisions where both gsvs were explanted.The ultrasound documented the absence of the gsvs.Patient is currently without symptoms and doing well.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
COVIDIEN LLC
951 aviation parkway
morrisville NC 27560
Manufacturer (Section G)
COVIDIEN LLC
951 aviation parkway
morrisville NC 27560
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key6680007
MDR Text Key78766776
Report Number3011410703-2017-00274
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeLO
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/21/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/30/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/01/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
Patient Weight56
-
-